The Senza Spinal Cord Stimulation (SCS) System is a type of neuromodulation technology, using an implanted pacemaker-like device to deliver electrical impulses to the spinal cord for chronic intractable pain of the trunk or limbs. It involves application of high frequency (10 kHz), short duration (30 ┬Ásec), low-amplitude (1-5 mA) pulses to the T8-T11 spinal epidural space in a specific treatment algorithm. This is known as HF10 therapy.
 
Status In progress
Process MT
ID number 330

Project Team

Project lead Liesl Millar

Email enquiries

Stakeholders

External assessment group Newcastle & York Consortium
Manufacturers Nevro Corporation
Manufacturers of related technologies not included in scope Medtronic Limited
  Abbott
  Boston Scientific
Others Department for Health and Social Care (DHSC)
  East Kent Hospitals NHS trust
  Healthcare Improvement Scotland (HIS)
  Johnson & Johnson Medical Ltd
  Medicines and Healthcare Products Regulatory Agency (MHRA)
  NHS England (NHSE)
  The James Cook University Hospital
  Health Quality Transformation
Professional groups Association of British Healthcare Industries (ABHI)
  Association of Healthcare Technology Providers for Imaging, Radiotherapy and Care (AXrEM)
  Royal College of Physicians
  British Society of Rehabilitation Medicine
  British Pain Society
  Devices for Dignity
  Medical Technology Group
  The British In Vitro Diagnostics Association (BIVDA)
  Neuromodulation Society of UK and Ireland (NSUKI)
  Spine Intervention Society (SIS)

Timeline

Key events during the development of the guidance:

Date Update
14 November 2018 Publication of the medical technology guidance on the Senza SCS has been paused temporarily. A new date for publication will be confirmed shortly. Please contact medtech@nice.org.uk if you have any questions.
10 October 2018 One or more resolution requests were received on this technology. An Initial Scrutiny meeting will take place on 15/10/2018 to agree if there has been a breach on either grounds for resolution (for more information please see section 6 of the programme process guide).
17 September 2018 Resolution
22 June 2018 Committee meeting: 3
20 April 2018 - 21 May 2018 Draft guidance: 2
13 April 2018 Following the public consultation on this technology, the medical technologies advisory committee's draft recommendations were changed. In accordance with section 5.11 of the medical technologies evaluation programme process guide, a second consultation will now take place. NICE will reissue the consultation document for a further public consultation on 20/04/2018.
23 March 2018 Committee meeting: 3
16 February 2018 Committee meeting: 2
05 December 2017 The final guidance meeting for this evaluation has been postponed from the 08 December meeting of the NICE medical technologies advisory committee. This page will be updated with a new date, along with estimated publication date, when known.
06 November 2017 - 04 December 2017 Draft guidance: 1
22 September 2017 Committee meeting: 1
23 May 2017 Scope published
26 April 2017 Stakeholder registration opens

For further information on how we develop guidance, please see our page about NICE medical technologies guidance